ClinicalTrials.Veeva

Menu

Cleancision IntRaoperative Contamination prEvention Study (CIRCE)

P

Prescient Surgical

Status

Completed

Conditions

Wound Contamination
Colorectal Surgery

Treatments

Device: CleanCision

Study type

Interventional

Funder types

Industry

Identifiers

NCT02413879
CLP-0001

Details and patient eligibility

About

This study entitled, An Evaluation of the Safety and Efficacy of the CleanCision Wound Retraction and Protection System in Protecting Surgical Incisions from Intraoperative Contamination When Used during Colorectal Surgery, is designed to evaluate contamination at the wound incision site when the CleanCision is used during surgery.

Full description

This study entitled, An Evaluation of the Safety and Efficacy of the CleanCision Wound Retraction and Protection System in Protecting Surgical Incisions from Intraoperative Contamination When Used during Colorectal Surgery, is designed to evaluate bacterial contamination at the wound incision site when the CleanCision is used during surgery. The CleanCision is a surgical tool that is designed to be used for the primary purpose of protecting the wound from contamination that occurs to the incision site during surgery ultimately reducing the occurrence of Surgical Site Infections (SSI).

This is a prospective, multi-center, single-arm (non-randomized) clinical study.

Enrollment

108 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 and older
  • BMI 15-45, inclusive
  • Colorectal surgery patient, planned resection
  • Incision length meets labeling requirements
  • Written informed consent using the governing IRB approved form

Exclusion criteria

  • Patients with a pre-existing stoma
  • Patients undergoing emergent colorectal surgery
  • Known history of contact hypersensitivity or allergy to device materials
  • Prior laparotomy or abdominal surgery within a timeframe that may present a safety risk or compromise study results
  • Active infection, sepsis or systemic antibiotic therapy within timeframe that may impact safety or study results
  • Active participation in any other clinical study of an experimental drug or device that may impact safety or study results
  • Postsurgical life expectancy is less than the study follow up period
  • Subject is pregnant or lactating
  • Subject is under incarceration
  • Subject considered to be inoperable following exploratory surgery

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

108 participants in 1 patient group

Treatment Group
Experimental group
Description:
All study subjects will be treated using the CleanCision device.
Treatment:
Device: CleanCision

Trial contacts and locations

7

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems